ATTO Technology to Highlight Certified Solutions at Dell(R) FRS 2016
Feb 08, 2016 22:16 pm UTC| Business
AMHERST, N.Y., Feb. 8, 2016 -- ATTO Technology, Inc. today announced that it will highlight its next generation connectivity portfolio at Dell FRS 2016, which takes place February 9 through 11 in Las Vegas. ATTO is a...
Monroe Bank & Trust Announces New Duties and Responsibilities for Senior and Executive Officers
Feb 08, 2016 22:00 pm UTC| Business
MONROE, Mich., Feb. 08, 2016 -- Effective immediately, Don Lieto, Executive Vice President Senior Administration Manager has accepted his new role as Executive Vice President, Continuity and Acquisition Integration...
The Southern Banc Company, Inc. Announces Second Quarter Earnings
Feb 08, 2016 21:55 pm UTC| Business
GADSDEN, Ala., Feb. 08, 2016 -- The Southern Banc Company, Inc. (OTCBB:SRNN), the holding company for The Southern Bank Company, formerly First Federal Savings and Loan Association of Gadsden, Alabama, announced a net...
Feb 08, 2016 21:51 pm UTC| Business
MCLEAN, Va., Feb. 08, 2016 -- Gladstone Capital Corporation (NASDAQ:GLAD) (the “Company”) today announced earnings for its first fiscal quarter ended December 31, 2015. Please read the Company’s Quarterly Report on Form...
WSFS to Present at the Keefe, Bruyette & Woods Winter Financial Services Symposium
Feb 08, 2016 21:50 pm UTC| Business
WILMINGTON, Del., Feb. 08, 2016 -- WSFS Financial Corporation (NASDAQ:WSFS), the parent company of WSFS Bank, today announced that Mark A. Turner, President and Chief Executive Officer, and Rodger Levenson, Chief...
Vital Launches Unique Zero-Cost Data Migration Imaging Service
Feb 08, 2016 21:40 pm UTC| Business
MINNEAPOLIS, Feb. 08, 2016 -- Vital Images, Inc. (Vital), a Minneapolis-based advanced medical imaging and informatics company, launch a zero-cost data migration service to the global marketplace. The company’s...
BeiGene Announces Closing of Its Initial Public Offering
Feb 08, 2016 21:30 pm UTC| Business
BEIJING, Feb. 08, 2016 -- BeiGene, Ltd. (“BeiGene” or “the Company”), a clinical-stage biopharmaceutical company focused on developing molecularly-targeted and immuno-oncological drugs for the treatment of cancer, today...